| Financial Year |
March 31 2023 |
| Monetary Funds |
2,617,837,305.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
808,895,577.81 |
| Accounts Receivable |
6,160,885,752.79 |
| Advances to Suppliers |
786,161,914.68 |
| Other Receivables |
138,323,079.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,895,601,932.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
157,907,865.65 |
| Total Current Assets |
23,140,106,056.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
590,570,061.42 |
| Investment Properties |
-- |
| Fixed Assetes |
3,816,201,447.18 |
| Under-construction Projects |
2,053,046,639.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,058,988,930.34 |
| R&D expenses |
705,127,560.76 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
145,405,221.10 |
| Other Non-Current Assets |
438,627,007.52 |
| Sub-Total of Non-Current Assets |
8,881,785,314.71 |
| Total Assets |
32,021,891,370.79 |
| Short-Term Loans |
5,919,300,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,524,595,966.48 |
| Accounts Payable |
4,896,978,022.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
85,821,623.19 |
| Taxes Payable |
55,360,917.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
234,665,502.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,458,508,410.99 |
| Other Current Liabilities |
182,447,330.69 |
| Sub-Total of Current Liabilities |
18,215,969,626.50 |
| Long-term Loans |
5,266,570,554.36 |
| Bonds Payable |
1,673,992,315.46 |
| Long-Term Accounts Payable |
42,401,817.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,370,057,821.15 |
| Total Liabilities |
25,586,027,447.65 |
| Paid-In Capital(Or Share Stock) |
3,371,975,400.00 |
| Capital Surplus |
2,222,679,885.97 |
| Surplus Reserve |
271,985,763.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-726,251,489.86 |
| Minority Stockholder's Interest |
1,306,224,043.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,129,639,879.57 |
| Owner's Equity（Stockholder's Equity） |
6,435,863,923.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,021,891,370.79 |
